Effective date
Medicare changes effective March 13, 2025
12 CMS and MAC policy updates take effect on this date across 2 MAC jurisdictions. Every entry links to the government document it came from.
CMS Coverage API · 12
- LCD L35922: Lab: Special Histochemical Stains and Immunohistochemical Stains — Palmetto GBA
LCD-L35922Palmetto GBAClinical Laboratorysource ↗
- LCD L37581: Lab: Cystatin C Measurement — Palmetto GBA
LCD-L37581Palmetto GBAClinical Laboratorysource ↗
- LCD L39264: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia — Noridian
LCD-L39264NoridianGastroenterologysource ↗
- LCD L39684: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — Noridian
LCD-L39684NoridianEndocrinologysource ↗
- LCD L37313: MolDX: Prometheus® IBD sgi Diagnostic® Policy — Noridian
LCD-L37313NoridianGastroenterologysource ↗
- LCD L39851: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) — Palmetto GBA
LCD-L39851Palmetto GBACardiologysource ↗
- LCD L37260: MolDX: Prometheus® IBD sgi Diagnostic® Policy — Palmetto GBA
LCD-L37260Palmetto GBAGastroenterologysource ↗
- LCD L39256: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia — Palmetto GBA
LCD-L39256Palmetto GBAGastroenterologysource ↗
- LCD L39646: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — Palmetto GBA
LCD-L39646Palmetto GBAEndocrinologysource ↗
- LCD L39237: Erythropoiesis Stimulating Agents — Palmetto GBA
LCD-L39237Palmetto GBAESRDsource ↗
- LCD L39258: Surgical Treatment of Nails — Palmetto GBA
LCD-L39258Palmetto GBADermatologysource ↗
- LCD L38745: Platelet Rich Plasma — Palmetto GBA
LCD-L38745Palmetto GBAMulti-specialtysource ↗